| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, COO &Interim CEO | President and COO
1 company
Cohlhepp Ryan is a President, COO &Interim CEO at BCAX. Recent filings cover 0 purchases and 29 sales. Those positions are worth an estimated $688K at current prices.
Our model assigns Cohlhepp Ryan a middling insider score of 52/100, based on 7 past trades. On a 3-month view, 57.1% of the rated trades came out ahead, averaging -0.1% over three months.
Cohlhepp Ryan's largest disclosed position is in BCAX as President, COO &Interim CEO, worth about $688K. The recent filings there lean toward selling, a net 215,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | BCAX Bicara Therapeutics Inc. | President, COO &Interim CEO | Sale+OE10b5-1 | 17,500 | $22.90 | $400,715.79 | -8.8% | - | - | |
| Aug 10, 2026 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 18,750 | $27.98 | $524,533.13 | -9.4% | - | - | |
| Jul 9, 2026 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 28,750 | $28.98 | $833,129.49 | -13.7% | -44.7% | - | |
| May 15, 2026 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 12,500 | $20.29 | $253,648.75 | -6.1% | +16.8% | - | |
| Apr 15, 2026 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 12,500 | $23.01 | $287,591.25 | -6.0% | +18.5% | - | |
| Mar 16, 2026 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 12,500 | $19.66 | $245,713.75 | -5.9% | +11.1% | - | |
| Mar 3, 2026 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 17,392 | $18.16 | $315,892.64 | -7.8% | +15.1% | - | |
| Feb 25, 2026 | BCAX Bicara Therapeutics Inc. | President and COO | Sale+OE10b5-1 | 3,631 | $18.04 | $65,501.42 | -1.7% | +25.5% | - | |
| Jan 22, 2026 | BCAX Bicara Therapeutics Inc. | President and COO | Sell10b5-1 | 3,828 | $18.10 | $69,295.99 | -1.8% | +34.3% | - | |
| Jan 15, 2026 | BCAX Bicara Therapeutics Inc. | President and COO | Sell10b5-1 | 149 | $18.02 | $2,684.98 | - | +42.1% | - |